Data / Drug companies / Melphalan hydrochloride
Melphalan hydrochloride: 14 companies and 14 products in the FDA NDC directory
Melphalan hydrochloride is listed in the FDA National Drug Code Directory by 14 companies, with 14 products in commercial distribution. 14 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are kit, and the newest product started marketing on March 28, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 14
- Generic (ANDA) products
- 14 (100.0%)
- Application numbers
- 9
- Routes
- Intravenous
- Brand names
- Melphalan
- openFDA record search
- api.fda.gov
Companies that list melphalan hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Arthur Group LLC | 1 | kit | Generic drugs (ANDA) | November 30, 2024 |
| Avenacy, LLC | 1 | kit | Generic drugs (ANDA) | December 18, 2023 |
| Bpi Labs LLC | 1 | kit | Generic drugs (ANDA) | July 2, 2021 |
| Camber Pharmaceuticals, Inc. | 1 | kit | Generic drugs (ANDA) | May 23, 2024 |
| Dr. Reddy's Laboratories Inc. | 1 | kit | Generic drugs (ANDA) | December 18, 2017 |
| Dr. Reddy's Laboratories Inc. | 1 | kit | Generic drugs (ANDA) | June 26, 2024 |
| Fosun Pharma USA Inc. | 1 | kit | Generic drugs (ANDA) | September 23, 2019 |
| Fresenius Kabi USA, LLC | 1 | kit | Generic drugs (ANDA) | December 22, 2017 |
| Gland Pharma Limited | 1 | kit | Generic drugs (ANDA) | June 10, 2019 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 1 | kit | Generic drugs (ANDA) | March 28, 2025 |
| Meitheal Pharmaceuticals Inc. | 1 | kit | Generic drugs (ANDA) | May 28, 2021 |
| Mylan Institutional LLC | 1 | kit | Generic drugs (ANDA) | January 10, 2013 |
| Qilu Pharmaceutical Co., Ltd. | 1 | kit | Generic drugs (ANDA) | December 18, 2023 |
| Sagent Pharmaceuticals | 1 | kit | Generic drugs (ANDA) | April 1, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Kit | 14 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 100% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.